International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study

Cited by (1,001)

Items 401–500 of 1,001

1. Quantifying motivational deficits and apathy: a review of the literature.
   M. Weiser, George Garibaldi · 2015 · European Neuropsychopharmacology
2. Effect of a Leucine-rich Repeat Kinase 2 Variant on Motor and Non-motor Symptoms in Chinese Parkinson’s Disease Patients
   Qian Sun, Tian Wang, Tianfang Jiang, Pei Huang, Dunhui Li, Ying Wang, Qin Xiao, Jun Liu, Shengdi Chen · 2016 · Aging and Disease
3. Emergence of non-motor fluctuations with reference to motor fluctuations in Parkinson's disease
   Aryun Kim, Han‐Joon Kim, Chaewon Shin, Ahro Kim, Yoon Hee Kim, Mihee Jang, Yu Jin Jung, Woong‐Woo Lee, Hye-Young Park, Beomseok Jeon · 2018 · Parkinsonism & Related Disorders
4. Introducing the Parkinson’s KinetiGraph into Routine Parkinson’s Disease Care: A 3-Year Single Centre Experience
   Thea Dominey, Angie A. Kehagia, Terry Gorst, Emma Pearson, Fiona Murphy, Emma King, Camille Carroll · 2020 · Journal of Parkinson s Disease
5. Non-Motor Symptoms of the Postural Instability and Gait Difficulty Subtype in De Novo Parkinson’s Disease Patients: A Cross-Sectional Study in a Single Center
   Jingru Ren, Ping Hua, Chenxi Pan, Yuqian Li, Li Zhang, Wenbin Zhang, Pingyi Xu, Minming Zhang, Weiguo Liu · 2020 · Neuropsychiatric Disease and Treatment
6. Emotional well-being and pain could be a greater determinant of quality of life compared to motor severity in cervical dystonia
   Lisa Klingelhoefer, Maximilian Kaiser, Anna Sauerbier, Robert Untucht, Miriam Wienecke, Könül Mammadova, Björn H. Falkenburger, Olaf Gregor, К. Ray Chaudhuri, Heinz Reichmann · 2020 · Journal of Neural Transmission
7. Characterization of Gastrointestinal Symptom Type and Severity in Parkinson's Disease: A Case–Control Study in an Australian Cohort
   Jade E. Kenna, Megan C. Bakeberg, Anastazja M. Gorecki, Chin Yen Tay, Samantha Winter, Frank Louis Mastaglia, Ryan S. Anderton · 2020 · Movement Disorders Clinical Practice
8. Profiling the most elderly parkinson’s disease patients: Does age or disease duration matter?
   Sasivimol Virameteekul, Onanong Phokaewvarangkul, Roongroj Bhidayasiri · 2021 · PLoS ONE
9. Evaluation and management of the non-motor features of Parkinson’s disease
   Steven Wishart, Graeme J.A. Macphee · 2010 · Therapeutic Advances in Chronic Disease
10. Impact of community pharmaceutical care on patient health and quality of drug treatment in Parkinson’s disease
    Sabrina Schröder, Peter Martus, Per Odin, Marion Schaefer · 2012 · International Journal of Clinical Pharmacy
11. Clinical risk–benefit assessment of dopamine agonists
    Jens Carsten Möller, Karla Maria Eggert, Marcus Michael Unger, Per Odin, К. Ray Chaudhuri, Wolfgang Hermann Oertel · 2008 · European Journal of Neurology
12. Nonmotor symptoms and health‐related quality of life in early Parkinson's disease
    Pablo Martínez‐Martín · 2013 · Movement Disorders
13. Treatment of motor fluctuations in Parkinson’s disease: recent developments and future directions
    Adolfo Ramirez‐Zamora, Eric Molho · 2013 · Expert Review of Neurotherapeutics
14. Pain Correlates with Sleep Disturbances in Parkinson's Disease Patients
    Yunting Fu, Chengjie Mao, Lijing Ma, Hui‐Jun Zhang, Yi Wang, Jie Li, Jun‐Ying Huang, Junyi Liu, Chun‐Feng Liu · 2017 · Pain Practice
15. Characterization of diplopia in non-demented patients with Parkinson's disease
    Katharina A. Schindlbeck, Shideh Schönfeld, Wanda Naumann, David J. Friedrich, André Maier, Charlotte Rewitzer, Fabian Klostermann, Frank Marzinzik · 2017 · Parkinsonism & Related Disorders
16. Restless Legs Syndrome
    William G. Ondo · 2009 · Neurologic Clinics
17. Absence of congruency sequence effects reveals neurocognitive inflexibility in Parkinson's disease
    Nabi Rustamov, Rea Rodriguez‐Raecke, Lydia Timm, Deepashri Agrawal, Dirk W. Dressler, Christoph Schrader, Pawel M. Tacik, Florian Wegner, Reinhard Dengler, Matthias Wittfoth et al. · 2013 · Neuropsychologia
18. Early recognition of pelvic floor dyssynergia and colorectal assessment in Parkinson's disease associated with bowel dysfunction
    C.-P. Wang, W. Sung, C.-C. Wang, Pei-Yien Tsai · 2013 · Colorectal Disease
19. Sleep/wake problems in Parkinson’s disease: pathophysiology and clinicopathologic correlations
    William G. Ondo · 2014 · Journal of Neural Transmission
20. Pain assessment in Indian Parkinson's Disease patients using King's Parkinson's Disease pain scale
    Madhuri Behari, Abhilekh Srivastava, Renu Achtani, Neha Nandal, Rupa Bala Dutta · 2020 · Annals of Indian Academy of Neurology
21. Deep brain stimulation for P arkinson disease in A ustralia: current scientific and clinical status
    Peter C. Poortvliet, Peter A. Silburn, Terry J. Coyne, Helen J. Chenery · 2015 · Internal Medicine Journal
22. The Possible Clinical Predictors of Fatigue in Parkinson’s Disease: A Study of 135 Patients as Part of International Nonmotor Scale Validation Project
    Vinod Metta, Kartik Logishetty, Pablo Martínez‐Martín, Heather Gage, Patricia Schartau, Tkpk Kaluarachchi, Anne Martin, Per Odin, Paolo Barone, Fabrizio Stocchi et al. · 2011 · Parkinson s Disease
23. Tolcapone addition improves Parkinson’s disease associated nonmotor symptoms
    Thomas H. Müller, for the TANIMOS Study Investigators · 2013 · Therapeutic Advances in Neurological Disorders
24. Comparison of frequencies of non motor symptoms in Indian Parkinson's disease patients on medical management versus deep brain stimulation: A case-control study.
    Kandadai Rukmini Mridula, Rupam Borgohain, Shaik Afshan Jabeen, Padmaja Gaddamanugu, VCS Srinivasarao Bandaru, Praveen Ankathi, Meena A Kanikannan, Mohammed Shujath Ali Khan · 2015 · PubMed Central
25. Objective intestinal function in patients with idiopathic REM sleep behavior disorder
    Karoline Knudsen, Tatyana Dmitrievna Fedorova, Allan K. Hansen, Michael Sommerauer, Anne‐Mette Haase, Kristina Bacher Svendsen, Marit Otto, Karen Østergaard, Klaus Krogh, Per Borghammer · 2018 · Parkinsonism & Related Disorders
26. In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson’s disease using neuromelanin-sensitive MRI: Replication in two cohorts
    Kristy Hwang, Jason A. Langley, Richa Tripathi, Xiaoping Philip Hu, Daniel E. Huddleston · 2023 · PLoS ONE
27. Prevalence and clinical profile of patients with restless legs syndrome in Parkinson's disease: A meta-analysis
    Gianpaolo Maggi, Angelo Barone, Clara Mastromarino, Gabriella Santangelo, Carmine Vitale · 2024 · Sleep Medicine
28. Parkinson Disease and Sleep: Sleep–Wake Changes in the Premotor Stage of Parkinson Disease; Impaired Olfaction and Other Prodromal Features
    Álex Iranzo · 2013 · Current Neurology and Neuroscience Reports
29. Clinical rating scales
    Maja Relja · 2011 · Parkinsonism & Related Disorders
30. Constipation Predicts Cognitive Decline in Parkinson’s Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group
    Diego Santos‐García, COPPADIS Study Group, Lucía García Roca, Teresa de Deus Fonticoba, Carlos Cores Bartolomé, Lucía Naya Ríos, Héctor Canfield, Jose M. Paz González, Cristina Martínez Miró, Silvia Jesús et al. · 2021 · Journal of Parkinson s Disease
31. Heart rate variability in Parkinson’s disease unaffected by deep brain stimulation
    Eftichia Trachani, Constantine Constantoyannis, George C Sakellaropoulos, Maria Stavrinou, George C. Nikiforidis, Elisabeth Chroni · 2011 · Acta Neurologica Scandinavica
32. Nonmotor Symptoms in a Malaysian Parkinson’s Disease Population
    Shahrul Azmin, Abdul Manaf Khairul Anuar, Hui Jan Tan, Wan Yahya Nafisah, Azman Ali Raymond, Othman Hanita, Shamsul Azhar Shah, Mohamed Ibrahim Norlinah · 2014 · Parkinson s Disease
33. Specific patient-reported outcome measures for Parkinson’s disease: analysis and applications
    Pablo Martínez‐Martín, Carmen Rodríguez‐Blázquez, Belén Frades Payo · 2008 · Expert Review of Pharmacoeconomics & Outcomes Research
34. Prevalence and Risk Factors for Minor Hallucinations in Patients with Parkinson’s Disease
    Min Zhong, Ruxin Gu, Sha Zhu, Yu Bai, Zhuang Wu, Xu Jiang, Bo Shen, Jun Zhu, Yang Pan, Jun Yan et al. · 2021 · Behavioural Neurology
35. Undetected ophthalmological disorders in Parkinson’s disease
    Carlijn D.J.M. Borm, Mario Werkmann, Debbie de Graaf, Femke Visser, Arno Hofer, Marina Peball, Katarzyna Śmiłowska, Diana Putz, Klaus Seppi, Werner H Poewe et al. · 2022 · Journal of Neurology
36. Perceived stigma and quality of life in Parkinson’s disease with additional health conditions
    Samia S Islam, Sandy A. Neargarder, Shraddha B. Kinger, Joshua T. Fox‐Fuller, Robert D. Salazar, Alice Cronin‐Golomb · 2022 · General Psychiatry
37. Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson’s disease
    Fabrizio Angius, Ignazia Mocci, Tommaso Ercoli, Francesco Loy, Laura Fadda, Maria Francesca Palmas, Giada Cannas, Aldo Manzin, Giovanni Defazio, Anna Rosa Carta · 2023 · Journal of Neurology
38. The Impact of Fatigue on Sleep and Other Non-Motor Symptoms in Parkinson’s Disease
    Ștefania Diaconu, Vlad Monescu, Rafaela Filip, L Evatt Marian, Cristian Kakucs, Iulia Murășan, К. Ray Chaudhuri, Dragoş Cătălin Jianu, Cristian Falup‐Pecurariu, Bianca Opriţoiu · 2024 · Brain Sciences
39. Non-motor symptoms in Chinese Parkinson’s disease patients with and without LRRK2 G2385R and R1628P variants
    Dawei Li, Zhuqin Gu, Chaodong Wang, Jinghong Ma, Beisha Tang, Shengdi Chen, Piu Chan · 2014 · Journal of Neural Transmission
40. Sexual Preoccupation Behavior in Parkinson’s Disease
    Gila Bronner, Sharon Hassin‐Baer, Tanya Gurevich · 2016 · Journal of Parkinson s Disease
41. Treatment of Nonmotor Symptoms in Parkinson's Disease
    Anna Sauerbier, Ilaria Cova, Miguel Rosa‐Grilo, Raquel N. Taddei, Laurie K. Mischley, К. Ray Chaudhuri · 2017 · International review of neurobiology
42. Dopaminergic Effect on Non-Motor Symptoms in Late Stage Parkinson’s Disease
    Kristina Rosqvist, Per Odin, Peter Hagell, Susanne Iwarsson, Maria H Nilsson, Alexander Storch · 2018 · Journal of Parkinson s Disease
43. Hierarchical Data-Driven Analysis of Clinical Symptoms Among Patients With Parkinson's Disease
    Tal Kozlovski, Alexis Mitelpunkt, Avner Thaler, Tanya Gurevich, Avi Orr‐Urtreger, Mali Gana‐Weisz, Netta Shachar, Tal Galili, Mira Marcus-Kalish, Susan Bressman et al. · 2019 · Frontiers in Neurology
44. Consistency and Stability of Motor Subtype Classifications in Patients With de novo Parkinson’s Disease
    Jingru Ren, Chenxi Pan, Yuqian Li, Lanting Li, Ping Hua, Ligang Xu, Li Zhang, Wenbin Zhang, Pingyi Xu, Weiguo Liu · 2021 · Frontiers in Neuroscience
45. Endothelial TDP-43 controls sprouting angiogenesis and vascular barrier integrity, and its deletion triggers neuroinflammation
    Víctor Arribas, Yara Onetti, Marina Ramiro‐Pareta, Pilar Villacampa, Heike Beck, Mariona Alberola, Anna Esteve‐Codina, Angelika Merkel, Markus Sperandio, Ofelia M. Martínez-Estrada et al. · 2024 · JCI Insight
46. Timing and Kinetics of Nonmotor Fluctuations in Advanced Parkinson’s Disease
    Christiana Ossig, Daniel Sippel, Mareike Fauser, Florin Gandor, Wolfgang H. Jost, Georg Ebersbach, Alexander Storch · 2017 · Journal of Parkinson s Disease
47. The Parkinson’s Real-World Impact Assessment (PRISM) Study: A European Survey of the Burden of Parkinson’s Disease in Patients and their Carers
    EDUARDO S. TOLOSA, Georg Ebersbach, Joaquim José Ferreira, Olivier Rascol, Angelo Antonini, Thomas Foltynie, Rachel Gibson, Diogo Magalhães, José‐Francisco Rocha, Andrew John Lees · 2021 · Journal of Parkinson s Disease
48. Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease
    Dafna Ben Bashat, Avner Thaler, Hedva Lerman, Einat Even‐Sapir, Matthew Hutchison, Karleyton C. Evans, Avi Orr‐Urtreger, Jesse M. Cedarbaum, Amgad Droby, Nir Giladi et al. · 2022 · npj Parkinson s Disease
49. Outcome Measures for Disease-Modifying Trials in Parkinson’s Disease: Consensus Paper by the EJS ACT-PD Multi-Arm Multi-Stage Trial Initiative
    Cristina Gonzalez‐Robles, Rimona Sharon Weil, Daniel J. van Wamelen, Michèle Bartlett, Matthew Burnell, Caroline Sarah Clarke, Michele T Hu, Brook Huxford, Ashwani Jha, Christian Lambert et al. · 2023 · Journal of Parkinson s Disease
50. Nonuniform Cardiac Denervation Observed by 11C-meta-Hydroxyephedrine PET in 6-OHDA-Treated Monkeys
    Valerie L. Joers, Kailie Seneczko, Nichole C. Goecks, Timothy J. Kamp, Timothy A. Hacker, Kevin G. Brunner, Jonathan W. Engle, Todd E. Barnhart, R. Jerome Nickles, James E. Holden et al. · 2012 · PLoS ONE
51. Fatigue assessment of Parkinson’s disease patient in clinic: specific versus holistic
    Cristian Falup‐Pecurariu · 2013 · Journal of Neural Transmission
52. Nonmotor Symptoms in Early- and Advanced-Stage Parkinson’s Disease Patients on Dopaminergic Therapy: How Do They Correlate with Quality of Life?
    Peter Valkovič, Ján Haršány, Marta Hanáková, Jana Martinkova, Ján Benetin · 2014 · ISRN Neurology
53. Epidemiology and clinical phenomenology for Parkinson's disease with pain and fatigue
    Hongbo Wen, Zhenxin Zhang, Han Wang, Ling Li, Honglei Chen, Yiming Liu, Baorong Zhang, Qun Xu · 2011 · Parkinsonism & Related Disorders
54. Re‐emergent tremor in Parkinson's disease: the effect of dopaminergic treatment
    Daniele Belvisi, Antonella Conte, Carolina Cutrona, Matteo Costanzo, Gina Ferrazzano, Giovanni Fabbrini, Alfredo Berardelli · 2018 · European Journal of Neurology
55. Nigral iron deposition in common tremor disorders
    Nina Homayoon, Lukas Pirpamer, Sebastian Franthal, Petra Katschnig, Mariella Kögl, Stephan Seiler, Karoline Wenzel, Edith Hofer, Hannes Deutschmann, Franz Fazekas et al. · 2018 · Movement Disorders
56. Predictive Factors of Fall-Related Activity Avoidance in People With Parkinson Disease—A Longitudinal Study With a 3-Year Follow-up
    Maria H Nilsson, Stina B. Jonasson, G. A. Rixt Zijlstra · 2020 · Neurology Report
57. Three year follow up of levodopa plus carbidopa treatment in a prevalent cohort of patients with Parkinson’s disease in Hai, Tanzania
    Catherine Louise Dotchin, Ahmed Jusabani, Richard William Walker · 2011 · Journal of Neurology
58. Measurement of Nonmotor Symptoms in Clinical Practice
    Pablo Martínez‐Martín, Carmen Rodríguez‐Blázquez, Maria João Forjaz, Monica M. Kurtis, Matěj Škorvánek · 2017 · International review of neurobiology
59. Non-Motor Symptoms: The Hidden Face of Parkinson’s Disease
    C. Cattaneo, Andrea Fabbrini, Daniele Belvisi, Flavia Aiello, Francesco Marchet, Giovanni Fabbrini · 2025 · Cells
60. The impact of deep brain stimulation on the nonmotor symptoms of Parkinson’s disease
    Keyoumars Ashkan, Michael Samuel, Prashanth Reddy, К. Ray Chaudhuri · 2012 · Journal of Neural Transmission
61. Non-Motor Features of Amyotrophic Lateral Sclerosis
    Abhishek Chowdhury, Adreesh Mukherjee, Uma Sinharoy, Alak Pandit, Atanu Biswas · 2021 · Annals of Indian Academy of Neurology
62. Adherence to Medication among Parkinson’s Disease Patients Using the Adherence to Refills and Medications Scale
    Branislava Radojević, Nataša Mišković, Andona Milovanović, Marina V. Svetel, Igor N. Petrović, Maja Pešić, Aleksandra Tomić, Dejana M. Stanisavljevic, Miroslav M. Savić, Vladimir Kostić · 2022 · International Journal of Clinical Practice
63. The roles of resilience and nonmotor symptoms in adjustment to Parkinson’s disease
    Andrea Shamaskin‐Garroway, Sarah K. Lageman, Bruce D. Rybarczyk · 2015 · Journal of Health Psychology
64. Anorectal dysfunctions in Parkinson's disease
    Joong‐Seok Kim, Hye Young Sung, Kwang-Soo Lee, Yeong-In Kim, Hee-Tae Kim · 2011 · Journal of the Neurological Sciences
65. Identifying barriers to help-seeking for non-motor symptoms in people with Parkinson’s disease
    Catherine S. Hurt, Lorna Rixon, К. Ray Chaudhuri, Rona E Moss-Morris, Mike Samuel, Richard G. Brown · 2016 · Journal of Health Psychology
66. Non-motor Symptoms in Patients with Parkinson’s Disease: A Cross-sectional Survey
    Khushbakht Tanveer, Immad Attique, Waleed Sadiq, Arsalan Ahmad · 2018 · Cureus
67. Characterizing Advanced Parkinson’s Disease: Romanian Subanalysis from the OBSERVE-PD Study
    József Attila Szász, Dragoş Cătălin Jianu, Mihaela Adriana Simu, Viorelia Adelina Constantin, Adriana Octaviana Dulămea, Koray Onuk, Diana Popescu, M. Vasile, Bogdan Ovidiu Popescu, Alfonso A. Fasano et al. · 2021 · Parkinson s Disease
68. Perceived walking difficulties in Parkinson’s disease – predictors and changes over time
    Magnus Lindh-Rengifo, Stina B. Jonasson, Susann Ullén, Niklas Mattsson, Maria H Nilsson · 2021 · BMC Geriatrics
69. The Influence of Serum Uric Acid Level on Non-Motor Symptoms Occurrence and Severity in Patients with Idiopathic Parkinson’s Disease and Atypical Parkinsonisms—A Systematic Review
    Anna Grażyńska, Klaudia Adamczewska, Sofija Antoniuk, M. Bień, Mateusz Toś, Jakub Kufel, Weronika Urbaś, Joanna S. Siuda · 2021 · Medicina
70. The Significance of Experiences of Nature for People with Parkinson’s Disease, with Special Focus on Freezing of Gait—The Necessity for a Biophilic Environment. A Multi-Method Single Subject Study
    Ottosson, Johan, Lavesson, Lillian, Pinzke, Stefan, Grahn, Patrik · 2015 · International Journal of Environmental Research and Public Health
71. Abnormal intrinsic brain activity of the putamen is correlated with dopamine deficiency in idiopathic rapid eye movement sleep behavior disorder
    Guanglu Li, Zhichun Chen, Liche Zhou, Mengsha Yao, Ningdi Luo, Wenyan Kang, Shengdi Chen, Jun Liu · 2019 · Sleep Medicine
72. Skin Temperature in Parkinson’s Disease Measured by Infrared Thermography
    Mathias M. Purup, Karoline Knudsen, Páll Karlsson, Astrid Juhl Terkelsen, Per Borghammer · 2020 · Parkinson s Disease
73. Non-motor symptoms in Parkinson's disease
    Barbosa, Egberto Reis · 2013 · Arquivos de Neuro-Psiquiatria
74. Patient-reported Needs, Non-motor Symptoms, and Quality of Life in Essential Tremor and Parkinson’s Disease
    Sarah K. Lageman, Therese Verkerke Cash, Melody Mickens · 2014 · Europe PMC (PubMed Central)
75. Anxiety and Levodopa Equivalent Daily Dose Are Potential Predictors of Sleep Quality in Patients With Parkinson Disease in Taiwan
    Chun‐Wei Chang, Jun‐Yu Fan, Bao‐Luen Chang, Yih‐Ru Wu · 2019 · Frontiers in Neurology
76. Staging Parkinson’s Disease Combining Motor and Nonmotor Symptoms Correlates with Disability and Quality of Life
    Diego Santos‐García, T. de Deus Fonticoba, Jose Manuel Paz González, Carlos Cores Bartolomé, Lorena Valdés Aymerich, José Guillermo Muñoz Enríquez, Ester Suárez, Silvia Jesús, M. Aguilar, Pau Pástor et al. · 2021 · Parkinson s Disease
77. Stereopsis and Eye Movement Abnormalities in Parkinson’s Disease and Their Clinical Implications
    Fang Ba, Tina T. Sang, Wenjing He, Jaleh Fatehi, Emanuel Mostofi, Bin Zheng · 2022 · Frontiers in Aging Neuroscience
78. Non-motor symptoms in amyotrophic lateral sclerosis: lessons from Parkinson’s disease
    Ali Shojaie, Silvia Rota, Ahmad Al Khleifat, К. Ray Chaudhuri, Ammar Al‐Chalabi · 2023 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
79. Comparing the effects of GBA variants and onset age on clinical features and progression in Parkinson's disease
    Jingru Ren, Xiaoyan Zhan, Hao Zhou, Zhiying Guo, Yi Xing, Hangxing Yin, Chen Xue, Jun Wu, Weiguo Liu · 2023 · CNS Neuroscience & Therapeutics
80. Proceedings of the Second Annual Deep Brain Stimulation Think Tank: What's in the Pipeline
    Aysegul Gunduz, Hokuto Morita, Peter Justin Rossi, William L. Allen, Ron L. Alterman, Helen M Bronte-Stewart, Christopher R. Butson, David P. Charles, Sjaak Deckers, Coralie de Hemptinne et al. · 2014 · International Journal of Neuroscience
81. Prevalence and determinants of depression in Mexican patients with Parkinson's disease
    Mayela Rodríguez‐Violante, Amin Cervantes‐Arriaga, Cecilia Berlanga‐Flores, Ángel Alberto Ruíz-Chow · 2012 · Clinical Neurology and Neurosurgery
82. The Hamburg Parkinson day-clinic: a new treatment concept at the border of in- and outpatient care
    Odette Fründt, Tina Mainka, Beate Schönwald, Bianca Müller, Polina Dicusar, Christian P Gerloff, Carsten Buhmann · 2018 · Journal of Neural Transmission
83. Self-reported autonomic symptoms in Parkinson's disease: properties of the SCOPA-AUT scale.
    Sevasti Bostantjopoulou, Zoe Katsarou, I Danglis, Haralambos Karakasis, D Milioni, Cristian Falup‐Pecurariu · 2016 · Europe PMC (PubMed Central)
84. Sleep matters in P arkinson's disease: use of a priority list to assess the presence of sleep disturbances
    Maartje Louter, Marjolein A. van der Marck, Dirk Pevernagie, Marten Munneke, Bastiaan R. Bloem, Sebastiaan Overeem · 2012 · European Journal of Neurology
85. Action-mode subnetworks for decision-making, action control, and feedback
    Carolina Badke D’Andrea, Timothy O. Laumann, Dillan J. Newbold, Charles J. Lynch, Mohammad Hadji, Steven M. Nelson, Ashley N. Nielsen, Roselyne J. Chauvin, Samuel R. Krimmel, Abraham Z. Snyder et al. · 2025 · Proceedings of the National Academy of Sciences
86. Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion in Parkinson's Disease: Real‐World Short‐Term Data on Tolerability, Infusion Rate Adjustments and Concomitant Medication
    Katarina Rukavina, Georg Ebersbach, Doreen Gruber · 2025 · Movement Disorders Clinical Practice
87. Predictors to quality of life improvements after subthalamic stimulation in Parkinson’s disease
    Fengtao Liu, Li‐Qin Lang, Yujie Yang, Jue Zhao, Rui Feng, Jie Hu, Jian Wang, Jianjun Wu · 2018 · Acta Neurologica Scandinavica
88. Relationship between risk and protective factors and clinical features of Parkinson's disease
    Daniele Belvisi, Roberta Pellicciari, Andrea Fabbrini, Matteo Costanzo, Gaia Ressa, Sara Pietracupa, Maria De Lucia, Nicola Modugno, Francesca Magrinelli, Carlo Dallocchio et al. · 2022 · Parkinsonism & Related Disorders
89. Progressive Olfactory Impairment and Cardiac Sympathetic Denervation in REM Sleep Behavior Disorder
    Annette Janzen, Dávid Vadász, Jan Booij, Markus Luster, Damiano Librizzi, Martin T. Henrich, Lars Timmermann, Mahboubeh Habibi, Elisabeth Sittig, Geert Mayer et al. · 2022 · Journal of Parkinson s Disease
90. Complement system changes in blood in Parkinson's disease and progressive Supranuclear Palsy/Corticobasal Syndrome
    Shervin Khosousi, Abdul Hye, Latha Velayudhan, Björn Bloth, Panagiota Tsitsi, Ioanna Markaki, Per Svenningsson · 2023 · Parkinsonism & Related Disorders
91. Quantifying Parkinson’s disease severity using mobile wearable devices and machine learning: the ParkApp pilot study protocol
    Gent Ymeri, Dario Salvi, Carl Magnus Olsson, Myrthe Wassenburg, Athanasios Tsanas, Per Svenningsson · 2023 · BMJ Open
92. Sleep disturbance in Parkinson disease
    Samrat Roychowdhury, Duncan R. Forsyth · 2012 · Journal of Clinical Gerontology and Geriatrics
93. Rating scales and questionnaires for assessment of sleep disorders in Parkinson’s disease: what they inform about?
    María Ascensión Zea‐Sevilla, Pablo Martínez‐Martín · 2014 · Journal of Neural Transmission
94. Patient-Reported Prevalence of Non-motor Symptoms Is Low in Adult Patients Suffering From 5q Spinal Muscular Atrophy
    René Günther, Claudia D. Wurster, Isabell Cordts, Jan Christoph Koch, Christoph Kamm, Daniel Petzold, Elisa Aust, Marcus Deschauer, Paul Lingor, Albert Christian Ludolph et al. · 2019 · Frontiers in Neurology
95. Frequency and Dynamics of Non-motor Symptoms Presentation in Hispanic Patients With Parkinson Disease
    Claudia Marisol Sánchez-Martínez, José Alberto Choreño-Parra, Noel Isaías Plascencia-Álvarez, Lilia Núñez-Orozco, Parménides Guadarrama-Ortíz · 2019 · Frontiers in Neurology
96. Les fluctuations non motrices de la maladie de Parkinson
    Tatiana Witjas, Elsa Kaphan, J.-P. Azulay · 2007 · Revue Neurologique
97. Non-motor symptoms in Chinese Parkinson’s disease patients
    Jing Gan, Mingzhu Zhou, Wei Chen, Zhenguo Liu · 2013 · Journal of Clinical Neuroscience
98. Subjective Cognitive Complaints in Newly-Diagnosed Parkinson’s Disease With and Without Mild Cognitive Impairment
    Chenxi Pan, Jingru Ren, Ping Hua, Lei Yan, Miao Yu, Yajie Wang, Gaiyan Zhou, Ronggui Zhang, Jiu Chen, Weiguo Liu · 2021 · Frontiers in Neuroscience
99. A Critical Analysis of Intestinal Enteric Neuron Loss and Constipation in Parkinson’s Disease
    Chelsea O’Day, David Isaac Finkelstein, Shanti Diwakarla, Rachel Mai McQuade · 2022 · Journal of Parkinson s Disease
100. Protective Effects of Flavonoid Rutin Against Aminochrome Neurotoxicity
     Fillipe Mendes de Araújo, Annyta Fernandes Frota, Lívia Bacelar de Jesus, Lorena Cuenca‐Bermejo, Kariny Maria Silva Ferreira, Cleonice Creusa dos Santos, Érica Novaes Soares, Jéssica Teles-Souza, Flávia Santos Sanches, Ana Carla S. Costa et al. · 2023 · Neurotoxicity Research